No Data
Prokidney skyrocketed by 500% in a single day: clinical breakthroughs meet the golden era of kidney disease.
ProKidney's 515% single-day increase is fundamentally a dual valuation by the market of 'technological breakthrough + sector benefits.' The underlying valuation logic primarily comprises four layers of expectations.
Regulus Signs Collaboration Agreement With Compania Minera Coimolache S.A. to Evaluate the Integrated Coimolache Sulphides/AntaKori Copper-Gold Project
Regulus Announces Delivery of Phase Two Metallurgical Samples to Nuton LLC, a Rio Tinto Venture
Regulus Provides Update on Exploration Activities and Community Initiatives
Regulus Reports Positive Nuton(TM) Technologies Extraction Rates on AntaKori Mineralization From Phase One Program
Regulus Appoints Adam Burley to Board of Directors and Provides Management Update